Eagle Meds Services
Mounjaro (tirzepatide) product image
Available to SourceHuman Prescription DrugDiabetes & Endocrine

Zepbound (Tirzepatide)

2.5 mg/.5mL · Injection Solution
By Eli Lilly and Company

Tirzepatide · Injectable Solution · 2.5 mg/.5mL · Subcutaneous

NDC
0002-2506
Route
Subcutaneous
Therapeutic class
G-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist , Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Marketing category
NDA

Package sizes

  • 4 SYRINGE in 1 CARTON (0002-2506-61) / .5 mL in 1 SYRINGENDC 0002-2506-61Available to Order
  • 4 SYRINGE in 1 CARTON (0002-2506-80) / .5 mL in 1 SYRINGE (0002-2506-01)NDC 0002-2506-80Available to Order
Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

  • DSCSA-compliant pedigree on every order
  • Cold-chain capable where applicable
  • Same-day fulfillment available for urgent needs
Requesting
Zepbound (Tirzepatide)
NDC 0002-2506